---

$251.00

+2.9200 ( +1.18% ) 1.4K

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).

Open	$251.00
Previous Close	$248.08
Volume	1.4K
Market Cap	$438.31B
Day Range	$248.25 - $251.40
52 Week Range	$184.63 - $261.64
Shares Outstanding	1.77B
Change %	+1.18%
Net Change	▲ 2.9200
Insider Ownership	N/A
Exchange	NYSE
Sector	Basic Materials
Industry	PHARMACEUTICAL PREPARATIONS
IPO Year	2012
Country	United States

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
No records found.